Phio Pharmaceuticals Statistics
Total Valuation
PHIO has a market cap or net worth of $5.88 million. The enterprise value is $819,902.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PHIO has 4.78 million shares outstanding. The number of shares has increased by 226.77% in one year.
Current Share Class | 4.78M |
Shares Outstanding | 4.78M |
Shares Change (YoY) | +226.77% |
Shares Change (QoQ) | +94.05% |
Owned by Insiders (%) | 0.08% |
Owned by Institutions (%) | 18.60% |
Float | 4.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.33 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.25 |
P/TBV Ratio | 1.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.38
Current Ratio | 6.38 |
Quick Ratio | 5.87 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -122.03% and return on invested capital (ROIC) is -75.72%.
Return on Equity (ROE) | -122.03% |
Return on Assets (ROA) | -60.11% |
Return on Invested Capital (ROIC) | -75.72% |
Return on Capital Employed (ROCE) | -149.78% |
Revenue Per Employee | n/a |
Profits Per Employee | -$824,333 |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.58% in the last 52 weeks. The beta is 1.27, so PHIO's price volatility has been higher than the market average.
Beta (5Y) | 1.27 |
52-Week Price Change | -79.58% |
50-Day Moving Average | 1.65 |
200-Day Moving Average | 2.93 |
Relative Strength Index (RSI) | 36.86 |
Average Volume (20 Days) | 92,023 |
Short Selling Information
The latest short interest is 68,910, so 1.44% of the outstanding shares have been sold short.
Short Interest | 68,910 |
Short Previous Month | 66,736 |
Short % of Shares Out | 1.44% |
Short % of Float | 1.44% |
Short Ratio (days to cover) | 0.50 |
Income Statement
Revenue | n/a |
Gross Profit | -3.67M |
Operating Income | -7.41M |
Pretax Income | -9.38M |
Net Income | -7.42M |
EBITDA | -7.40M |
EBIT | -7.41M |
Earnings Per Share (EPS) | -$12.64 |
Full Income Statement Balance Sheet
The company has $5.39 million in cash and n/a in debt, giving a net cash position of $5.39 million or $1.13 per share.
Cash & Cash Equivalents | 5.39M |
Total Debt | n/a |
Net Cash | 5.39M |
Net Cash Per Share | $1.13 |
Equity (Book Value) | 4.95M |
Book Value Per Share | 5.16 |
Working Capital | 4.95M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -8.11M |
Capital Expenditures | n/a |
Free Cash Flow | -8.11M |
FCF Per Share | -$1.70 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -226.77% |
Shareholder Yield | -226.77% |
Earnings Yield | -119.47% |
FCF Yield | -130.61% |
Analyst Forecast
The average price target for PHIO is $4.00, which is 225.20% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 225.20% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 5, 2024. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |